Collaborative Framework to take Imaging Technology forward

A long-term strategic partnership announced by The European Molecular Biology Laboratory (EMBL) and ZEISS aims to close the gap between early-stage imaging technology development and its application in life science research through a shared resources agreement. This will allow users of EMBL’s Imaging Centre access to the latest microscopy technologies and expertise from ZEISS, while research and projects carried out by users will provide the company  with invaluable insights into new applications and opportunities for market-testing recent technology developments.

Regular strategic discussions will also provide a unique opportunity for the partners to engage in joint technology development. The new agreement was negotiated with support from EMBL’s technology transfer arm EMBLEM.

“EMBL and ZEISS have been working together fruitfully on multiple microscopy projects for decades and we are excited to take the next step in our relations and give it a strategic perspective in this new framework agreement,” said Jan Ellenberg, Head of the EMBL Imaging Centre.

Michael Albiez, Head of ZEISS Research Microscopy Solutions, stated: “This collaboration is creating new ways for both EMBL and ZEISS to interact and work together. The cutting-edge research performed in the EMBL Imaging Centre and EMBL as a whole will be an ideal testing and development environment for our next generation of imaging technologies.”

The collaboration focuses on three areas: the joint development and application testing of new imaging technologies, joint activities in Open Data and training.

More information online